McCourt Marion sold REGN
May 1, 2024 · Form 4 insider transaction
McCourt Marion sold 250 shares of Regeneron Pharmaceuticals, Inc. at $889.41 per share, a transaction worth $222.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
250
Price
$889.41
Total value
$222.4K
InsiderMcCourt Marion
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 1, 2024
Filing dateMay 3, 2024
Shares owned after12,931
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023.